Sandler Neurosciences Building, Neurological Clinical Research Unit

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy	CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Multiple Sclerosis, Primary Progressive, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis	Recruiting	Phase 1 / Phase 2	2026-07-02		NCT05359653
Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy	Brain Diseases, Metabolic, Clinically Isolated Syndrome, CNS Demyelinating, Marchiafava-Bignami disease, brain disorder, central nervous system disorder, demyelinating disease, nervous system disorder	Not yet recruiting	Phase 1 / Phase 2	2026-03-11		NCT06065670

Clinical trials